Literature DB >> 6845655

Immunochemical identification of rubella virus hemagglutinin.

M N Waxham, J S Wolinsky.   

Abstract

Purified rubella virus contains three major structural polypeptides whose apparent molecular weights are 62,000, a 47,000-54,000 complex, and 38,000 when analyzed by polyacrylamide gel electrophoresis. Both the 62,000 and 47,000-54,000 dalton polypeptides are glycosylated, but they vary in their relative [3H]glucosamine and [3H]mannose content. Limited-digest peptide maps confirm that each polypeptide is distinct and that the 47,000-54,000 dalton complex is a series of three glycopolypeptides with extensive similarities. Under nonreducing conditions, both the 62,000 dalton glycopolypeptide and the 47,000-54,000 dalton complex exist as monomers and also as disulfide-linked complexes. A complex of 105,000 daltons is a dimer of the 62,000 dalton glycopolypeptide and a second, at 95,000 daltons, is a mixed disulfide-bonded dimer of the 62,000 dalton glycopolypeptide and 47,000-54,000 dalton complex. The 38,000 dalton polypeptide migrated exclusively as a dimer of 78,000 daltons when unreduced. Two monoclonal antibodies which inhibit the hemagglutinin function of the virus were shown to be directed against the 62,000 dalton glycopolypeptide. This glycoprotein is therefore responsible at least in part for the hemagglutinin function of rubella virus.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6845655     DOI: 10.1016/0042-6822(83)90471-3

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  34 in total

1.  The E2 signal sequence of rubella virus remains part of the capsid protein and confers membrane association in vitro.

Authors:  M Suomalainen; H Garoff; M D Baron
Journal:  J Virol       Date:  1990-11       Impact factor: 5.103

2.  Structure of rubella E1 glycoprotein epitopes established by multiple peptide synthesis.

Authors:  L Lozzi; M Rustici; M Corti; M G Cusi; P E Valensin; L Bracci; A Santucci; P Soldani; A Spreafico; P Neri
Journal:  Arch Virol       Date:  1990       Impact factor: 2.574

3.  Localization of the labile disulfide bond between SU and TM of the murine leukemia virus envelope protein complex to a highly conserved CWLC motif in SU that resembles the active-site sequence of thiol-disulfide exchange enzymes.

Authors:  A Pinter; R Kopelman; Z Li; S C Kayman; D A Sanders
Journal:  J Virol       Date:  1997-10       Impact factor: 5.103

4.  Specific binding of host cell proteins to the 3'-terminal stem-loop structure of rubella virus negative-strand RNA.

Authors:  H L Nakhasi; X Q Cao; T A Rouault; T Y Liu
Journal:  J Virol       Date:  1991-11       Impact factor: 5.103

5.  Rubella virus antigens: localization of epitopes involved in hemagglutination and neutralization by using monoclonal antibodies.

Authors:  K Y Green; P H Dorsett
Journal:  J Virol       Date:  1986-03       Impact factor: 5.103

6.  Detection of rubella virus-specific immunoglobulin G (IgG), IgM, and IgA antibodies by immunoblot assays.

Authors:  T Zhang; C A Mauracher; L A Mitchell; A J Tingle
Journal:  J Clin Microbiol       Date:  1992-04       Impact factor: 5.948

7.  Monoclonal antibodies directed to E1 glycoprotein of rubella virus.

Authors:  Y Umino; T A Sato; S Katow; T Matsuno; A Sugiura
Journal:  Arch Virol       Date:  1985       Impact factor: 2.574

8.  Construction of rubella virus genome-length cDNA clones and synthesis of infectious RNA transcripts.

Authors:  C Y Wang; G Dominguez; T K Frey
Journal:  J Virol       Date:  1994-06       Impact factor: 5.103

9.  Expression and characterization of virus-like particles containing rubella virus structural proteins.

Authors:  Z Qiu; D Ou; T C Hobman; S Gillam
Journal:  J Virol       Date:  1994-06       Impact factor: 5.103

10.  Rubella virus 40S genome RNA specifies a 24S subgenomic mRNA that codes for a precursor to structural proteins.

Authors:  C Oker-Blom; I Ulmanen; L Kääriäinen; R F Pettersson
Journal:  J Virol       Date:  1984-02       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.